Development of the human placenta


Margherita Y. Turco1,2,3* and Ashley Moffett1,2


1Centre for Trophoblast Research, 2 Department of Pathology and 3Department of Physiology, Neuroscience and Development
University of Cambridge, UK

*Corresponding author:  myt25@cam.ac.uk


ABSTRACT 

The placenta is essential for normal in utero development in mammals. In humans, defective placental formation underpins common pregnancy disorders such as pre-eclampsia and fetal growth restriction. The great variation in placental types across mammals means that animal models have been of limited use in understanding human placental development. However, new tools to study human placental development, including 3D organoids, stem cell culture systems and single cell RNA sequencing, have brought new insights into this field. Here, we review the morphological, molecular and functional aspects of human placental formation with a focus on the defining cell of the placenta - the trophoblast.  






Introduction
The placenta is the largest fetal organ and the first to develop.  It plays a central role in the health of both the fetus and its mother, and has a lifelong impact on their future wellbeing. Indeed, disordered placental development is the primary defect in major diseases of pregnancy, such as pre-eclampsia, fetal growth restriction, recurrent miscarriage, and still-birth (Brosens et al., 2011). The links between the in utero environment and susceptibility to chronic disease in adults are also well recognized (Barker, 1995). However, despite its importance in reproductive success, there is still limited understanding of how the human placenta develops. The obvious ethical and logistical obstacles in investigating early human pregnancy, and the lack of long term, physiologically relevant in vitro models, make experimentation problematic. This is further compounded by the great diversity of strategies used by different eutherian mammals to build a placenta, which make extrapolating data from other species to humans difficult (Carter and Enders, 2004).
Here, we provide a broad overview of current knowledge of human placental development, based on morphological studies of archival specimens, immunohistochemical and bulk transcriptome analyses, and in vitro studies using primary cells, cell lines and villous explants. We also highlight recent technological advances, such as comparative genomic and transcriptomic studies at the single cell level, organoid culture systems, and systematic analyses of biomarkers for placental function, that now allow us to study the early stages of human placental development in more detail. 
	
Anatomy of human placental development 
The human placenta develops from the trophectoderm (TE), the outer layer of the pre-implantation embryo, which forms at ~5 days post fertilization (dpf). At this stage, the pre-implantation embryo (termed a blastocyst) is segregated into two lineages: the inner cell mass (ICM) and the TE. The polar TE (the part of the TE that is contiguous with the underlying ICM) attaches to the surface epithelium of the uterine mucosa, the endometrium (Figure 1a). Although the earliest stages of implantation have not been visualized in humans, morphological observations of early pregnant hysterectomy specimens and higher primates suggest that, following attachment to the uterine surface epithelium at ~6-7dpf, the TE fuses to form a primary syncytium.  This is the prelacunar period phase of placental development (Boyd and Hamilton, 1970). 
Following implantation, the primary syncytium quickly invades through the surface epithelium into the underlying endometrium, which is transformed during pregnancy into a specialized tissue known as decidua (Figure 1b) (Schlafke and Enders, 1975). By the time of the first missed menstrual period (~14dpf), the blastocyst is completely embedded in the decidua and is covered by the surface epithelium (Figure 1c) (Hertig et al., 1956). Fluid-filled spaces (lacunae) then appear within the syncytial mass that enlarge and merge, partitioning it into a system of trabeculae. This is the lacunar stage. The syncytium also erodes into decidual glands, allowing secretions to bathe the syncytial mass (Hertig et al., 1956). 
The trophoblast cells beneath the syncytium (termed inner cytotrophoblast cells) are initially not in direct contact with maternal tissue but rapidly proliferate to form projections that push through the primary syncytium to form primary villi (a cytotrophoblast core with an outer layer of syncytiotrophoblast, SCT); this is the villous stage of development (Fig. 1d). The villous trees are formed by further proliferation and branching, and the lacunae become the intervillous space. Cytotrophoblast cells eventually penetrate through the primary syncytium and merge laterally to surround the conceptus in a continuous cytotrophoblast shell between the villi and the decidua (Figure 1d). The blastocyst is now covered by three layers: the inner chorionic plate in contact with the original cavity, the villi separated by the intervillous space and the cytotrophoblast shell in contact with the decidua.
Soon afterwards, around day 17-18, extra-embryonic mesenchymal cells penetrate through the villous core to form secondary villi. By day 18dpf, fetal capillaries appear within the core, marking the development of tertiary villi.  The villous tree continues to rapidly enlarge by progressive branching from the chorionic plate to form a system of villous trees. Where the cytotrophoblast shell is in contact with the decidua (the maternal-fetal interface), individual cytotrophoblast cells leave the shell to invade into decidua as extravillous trophoblast (EVT) in a process closely resembling epithelial-mesenchymal transition (EMT). In this way, by the end of the first trimester, the blueprint of the placenta is established.  

Cell types of the human placenta
Trophoblast cells 
The major functions of the placenta are performed by trophoblast cells. The appearance of trophoblast is an important evolutionary advance that defines placental mammals.  The term ‘trophoblast’ was first used by the Dutch embryologist Ambrosius Arnold Willem Hubrecht in 1889 to describe cells that transport nutrients and form the protective barrier between mother and fetus (Pijnenborg and Vercruysse, 2013). He also observed that the trophoblast is inherently highly invasive or ‘corrosive’ and dependent on decidua to support its development (Hubrecht, 1908). Since these early studies, a variety of human trophoblast subtypes have been identified. These include SCT, VCT and subtypes of EVT.
The SCT is the outer lining of the placental villi in direct contact with maternal glandular secretions, and later maternal blood flowing into the intervillous space (Figure 2). It is the main site of maternal/fetal exchange of gases and nutrients necessary for the growth of the feto-placental unit. SCT has a highly polarized epithelial layer densely covered with microvilli, which increases its surface area 5-7 fold (Teasdale and Jean-Jacques, 1985). Microinjection of fluorescein-labeled dextrans into SCT confirms that it is multinucleated with no cell borders, presumably to facilitate diffusion across its entire structure and protect the fetus from pathogens (Gaunt and Ockleford, 1986). Proteomic analyses of SCT membranes show that the microvilli are rich in receptors for growth factors and hormones (Robinson et al., 2009). Both the apical and basal membranes of SCT are packed with transporter proteins for amino acids, glucose as well as those to efflux xenobiotics. SCT is also a major endocrine organ, secreting hormones and proteins into the maternal circulation to drive the physiological and metabolic adaptations to pregnancy. Furthermore, SCT functions as a protective immunological barrier because it never expresses any Human Leukocyte Antigens (HLA) molecules meaning that, despite the presence of the allogeneic fetus, circulating immune cells will not detect the SCT as ‘non-self’ (Moffett and Loke, 2006). The SCT also expresses the neonatal Fc receptor (FcRn) that allows transport of maternal IgG antibodies to the fetal circulation (Roopenian and Akilesh, 2007). The antibodies that preferentially bind to FcRn on SCT are digalactosylated IgG1 that are effective at activating fetal NK cells to protect the neonate before birth (Jennewein et al., 2019).
The mononuclear VCT lies beneath the SCT on a basement membrane (Figure 2). Historically, VCT have been considered the ‘germinative’ layer of trophoblast because they are mitotic and express proliferative markers (Simpson et al., 1992).  In early pregnancy, when they form a continuous layer, VCT are cuboidal with a large nucleus:cytoplasm ratio. As the villous trees expand, the VCT layer becomes discontinuous and covers only 25% of the villous surface by term when only a thin syncytial layer separates most of the villous core from maternal blood (Benirschke et al., 2012). 
As the placenta enlarges, the cytotrophoblast shell becomes discontinuous and cytotrophoblast cell columns (CCCs) emerge from the distal tips of the anchoring villi in contact with the decidua (Figure 2). The cells in the columns are rounded, cohesive and rich in glycogen. From the shell, and later the anchoring villi, the EVT migrate into the decidua along two differentiation pathways: interstitial EVT (iEVT) migrate through the decidual stroma towards the maternal spiral arteries, while endovascular trophoblast EVT (eEVT) move down the inside of the spiral arteries (Pijnenborg et al., 1980). In the decidua, iEVT have a pleomorphic and fusiform morphology, tetraploid nuclei, are non-cycling and show changes of senescence (Velicky et al., 2018).  They home towards the spiral arteries to form a cuff of surrounding cells. This is associated with loss of actin in smooth muscle cells of the arterial media, which is replaced by amorphous eosinophilic material resulting in the histological appearance known as ‘fibrinoid’ change (Pijnenborg et al., 2006). This trophoblast-mediated transformation of the artery results in loss of vasoactivity and conversion into a vessel capable of high conductance at low pressure, an essential adaptation for normal pregnancy (Brosens et al., 1967). The iEVT invade as far as the inner third of the myometrium (the muscular layer of the uterine wall), where they fuse to form placental bed giant cells (Pijnenborg et al., 1980).  After the arterial transformation occurs, eEVT move in a retrograde manner down the artery to form a plug  that prevents blood entering the intervillous space until towards the end of the first trimester, when  the full haemochorial circulation is established (Boyd and Hamilton, 1970; Burton et al., 1999; Hustin and Schaaps, 1987).   

Other placental cells
Besides trophoblast, the placenta contains a range of cells present within the stromal core of the villi, including fibroblasts, immune and vascular cells (Figure 2). These cells are all thought to be generated from the extra-embryonic mesenchyme whose origin in humans is uncertain. Suggestions are that it arises from VCT that undergoes EMT, or that it originates from the hypoblast, the endodermal derivative of the ICM, with contribution from the embryonic mesoderm after gastrulation (Boss et al., 2018). 
Single cell RNA sequencing (scRNA-seq) of first trimester villi shows there are at least two fibroblast populations distinguished by the presence or absence of the imprinted gene DLK1 (Kagami et al., 2012; Vento-Tormo et al., 2018). DLK1+ cells have similarities to pericytes and may be involved in vascular development (Liu et al., 2018; Suryawanshi et al., 2018). The fibroblasts link up to form a network of canals that feed into the extra-embryonic coelom. These canals contain placental macrophages termed Hofbauer cells (Burton, 1987; Castellucci et al., 2000; Kaufmann et al., 1977). Because Hofbauer cells are the only immune cells in the placenta and appear in the villous core from around day 18 p.c, before there is any vascular connection to the embryo itself, they are likely to be generated from haemangioblastic cells in extra-embryonic tissue (Boyd and Hamilton, 1970; Castellucci et al., 1987). Their functions have been little investigated but they are likely to play roles in protecting the fetus from vertical infections, influencing trophoblast and placental vascular development and transferring nutrients to the extra-embryonic coelom. The vascular system also develops from haemangioblastic populations in the mesenchyme and connects to the fetus via the umbilical cord by the end of the first trimester (Dempsey, 1972; Robin et al., 2009). These immature endothelial cells have a specific pattern of gene expression; for example, they express EGFL7, which is known to regulate vascular morphogenesis (Parker et al., 2004).

Models for the study of human placental development
Animal models
Mammals exhibit an enormous diversity of placental strategies, in particularly with regard to the degree of trophoblast invasion into uterine tissues and the number of cell layers between the maternal and fetal circulations (Roberts et al., 2016). Both the laboratory mouse and primates have a haemochorial type of placenta, where the trophoblast invades through the uterine epithelium, stroma and maternal arterial walls to come into direct contact with maternal blood (Georgiades et al., 2002). Lesser degrees of invasion are seen in carnivores with an endotheliochorial placenta, where trophoblast cells contact maternal endothelial cells. In the least invasive form, an epitheliochorial placenta, which is characteristic of ruminants and ungulates, the trophoblast remains superimposed on the uterine epithelium (Carter and Enders, 2013). 
	There is no perfect experimental model to investigate human placentation, even in species with haemochorial placentas (e.g. the laboratory mouse and non-human primates) (Carter and Pijnenborg, 2011). An additional problem is that, from the vantage point of an obstetrician, disorders like pre-eclampsia, where the primary defect is failure of placentation, are unique to humans and possibly great apes (Carter, 2011). The differences between mouse and human placentation are considerable. In humans, the polar TE attaches to the uterus whereas, in mice, it is the mural TE (which lies opposite the ICM) that implants into the uterus first, followed by the polar TE that will give rise to the ectoplacental cone (EPC) (Georgiades et al., 2002). Moreover, EPC cells are mononuclear, and their invasion into the decidua occurs almost half way through murine gestation, unlike the initial invasion by primary syncytium in humans. The EPC in mice forms the spongiotrophoblast and, although this is viewed as equivalent to the EVT in humans, there is no deep interstitial invasion of the decidua. This type of invasion is characteristic only of humans and great apes (gorillas and chimpanzees) and is not seen in other primates (Pijnenborg et al., 2011). Unlike the human villous placenta, the site of placental exchange in rodents is the labyrinth that has a complex tightly packed arrangement of maternal and vascular channels. These substantial differences in trophoblast development between mouse and humans means that findings obtained in studies of the mouse must be treated with a certain degree of healthy skepticism.  Indeed, genome-wide expression profiling of mouse and human placentae across gestation has revealed clusters of genes with quite different co-expression patterns (Soncin et al., 2018). 
Despite these caveats, important insights can nonetheless be made from studying murine genetic knock-out models of in utero fetal loss (Rossant and Cross, 2001). In ~70% cases, the phenotype is attributable to placental abnormalities and several of the genes identified from this approach are known to play a role in EMT (Perez-Garcia et al., 2018b). A better rodent model to study arterial transformation is the laboratory rat as, in this system, the trophoblast extends deeply into the uterine wall to remodel the artery feeding the placentation site  (Soares et al., 2012).

In vitro models
Until recently, the study of human placental development and trophoblast specification and differentiation had been hampered by the lack of reliable, physiologically relevant and reproducible in vitro models. While various cell lines and models are available, they do not all retain key features of the equivalent cells in vivo. However, recent advances have led to the development of more robust in vitro systems that can be used to model human placentation.

Trophoblast cell lines
A major problem has been the lack of consensus about how to define human trophoblast in vitro, with a wide range of features being used in each case (King et al., 2000a). This is the issue for the various cell lines that have been derived from first trimester or term placentas, so their identity is still not clear (Feng et al., 2005; Genbacev et al., 2011; Genbacev et al., 2016; Graham et al., 1993; James et al., 2007; James et al., 2015; Perez-Garcia et al., 2018a; Straszewski-Chavez et al., 2009; Takao et al., 2011; Zdravkovic et al., 2015). Care must be taken as contaminating maternal epithelial and fetal mesenchymal cells can outgrow trophoblast isolated from the placenta (Heazlewood et al., 2014; Turco et al., 2018).  We recently proposed that four criteria could together be used to characterise human first trimester (post-implantation) trophoblast: expression of genes highly expressed in trophoblast, such as TFAP2C, GATA3 and cytokeratin (KRT7); unique pattern of HLA expression, either HLA null (VCT and SCT) or HLA-G+, HLA-C+ but HLA-A- and HLA-B- (EVT); very high expression of the C19MC microRNA complex; and hypomethylation of the ELF5 promoter (Lee et al., 2016a). The analysis of ELF5 methylation and HLA class I expression indicates that most of these lines do not share the profile of in vivo first trimester trophoblast and may be mesenchymal cells (Abou-Kheir et al., 2017; Hemberger et al., 2010a; King et al., 2000a).  This is the first attempt to define human trophoblast in vitro but undoubtedly improvements will be made in the future.  

Choriocarcinoma cell lines
Although the cell lines derived from choriocarcinomas (malignant tumours of trophoblast), JEG3, JAR and BeWo, do fulfill the four criteria defining trophoblast, and have been widely used in vitro models, their genetic signatures are quite unlike that of normal trophoblast (Apps et al., 2009; Poaty et al., 2012). BeWo cells are derived from metastatic deposits of a gestational choriocarcinoma that were passaged >300 times within the hamster cheek pouch. The JEG-3 line was subcloned from BeWo; both are hypertriploid with ~70 chromosomes (Hertz, 1959; Kohler and Bridson, 1971; Pattillo and Gey, 1968). JAR cells are HLA null, like VCT; however, although JEG3 cells, like EVT, do express HLA-G and HLA-C, the HLA-G dimers characteristic of normal trophoblast are absent and only HLA-G monomers are expressed (Apps et al., 2007). This limits the experimental use of JEG3 cells as targets for maternal uterine immune cells (NK cells and myeloid cells) that express the LILRB1 receptor for the dimeric form of HLA-G dimers (Shiroishi et al., 2006). Moreover, genome wide DNA methylation studies comparing primary trophoblast to many of these cell lines show significant variability in their profiles that are likely to contribute to differential expression profiles (Apps et al., 2011; Novakovic et al., 2011). This highlights the caution needed for interpreting results using cell lines and the importance of validating findings by using primary cells. Indeed, much of the controversy in the literature has arisen from using cell lines that are not representative of bona fide trophoblast cells in vivo.  

Human embryonic stem cell-derived trophoblast cells 
Another approach has been to differentiate human embryonic stem cells (hESCs)  into trophoblast cells by culturing them in the presence of BMP4 and inhibitors of FGF2 and TGFβ signalling (Amita et al., 2013; Xu et al., 2002). A comprehensive analysis of all the reports using this method, and discussion of how the culture conditions and different hESC lines used can affect trophoblast differentiation (including the source of suppliers for BMP4), is available (Roberts et al., 2018). Characterisation of such hESC-derived trophoblast cells using our four putative trophoblast criteria is incomplete, but it has been shown that these cells exhibit partial (but not complete) hypomethylation of the ELF5 promoter and downregulate some of the microRNAs from the C19MC complex (Lee et al., 2016b). Formation of SCT secreting human chorionic gonadotropin (hCG) and expression of the EVT marker, HLA-G, are reported as well as other genes expressed by trophoblast such as KRT7, GATA2 and TCFAP2A. Transcriptomic analysis of hESC-derived trophoblast reveals that these cells are different from both term trophoblast and mesoderm lineage; this has been a subject of discussion as some markers are expressed in both cell types (Bernardo et al., 2011; Jain et al., 2017). A defining feature of trophoblast, the absence of HLA-A and HLA-B has not yet been analysed in these cells. Thus, while this approach seems to promote some transition towards the trophoblast lineage, the identity of the trophoblast cells generated and the cells they are most similar to in vivo is still unclear. One possibility is that hESC-derived trophoblast cells represent an early postimplantation trophoblast population (Roberts et al., 2018). 

Placental explants or primary trophoblast cells
Many labs have used explants of placenta or isolates of primary placental cells. Explants are prepared from the villous placenta and adhere to plastic or a defined matrix.  Extravillous HLA-G+ cells then move away from the tips of the villi. Preparations of primary isolates of trophoblast and other placental cells can be obtained from early gestation or at term.  At term, because the VCT is not easily visible by light microscopy and only a thin layer of SCT covers the villi, any placental isolates may potentially contain other cells from the villous core (Hofbauer cells, fibroblast and endothelial cells) as well as maternal and fetal blood cells together with attached decidual cells. In the first trimester, the villi are covered by SCT and an inner layer of VCT; the latter that can be isolated by enzymatic digestion and density gradient sedimentation (Male et al., 2012). However, the cells need to be plated onto an ECM matrix as they adhere poorly to plastic; after overnight culture they are all HLA-G+. The cells can be used within 3-4 days but within a week the cultures become overgrown by mesenchymal contaminants as these trophoblast cells do not proliferate in vitro. Other placental cells from the villous core can also be isolated and phenotypic markers such as CD34 for endothelial cells can be used to verify purity. The problems with using primary cells for experimentation are obvious; ethical permission is essential, limiting use to certain countries and requiring good liaison with clinical staff. There are also several difficulties relating to cell viability, degeneration of SCT, and reproducibility. Indeed, the innate variability between samples, which depends on factors such as gestational age, parity, intercurrent disease and area of placenta sampled, means that multiple experiments are needed to ensure validity of results.

Trophoblast stem cells and organoids
Embryo culture beyond the stage of human implantation has allowed visualisation of reorganisation of the embryo and formation of the early trophoblast lineages up to day 13, although the molecular mechanisms underlying these events are still unknown (Deglincerti et al., 2016; Shahbazi et al., 2016). Progress has been now made in generating bona fide human trophoblast stem cells (hTSCs) from both trophectoderm and first trimester placentas (Okae et al., 2018). hTSCs are grown on collagen IV and can be cultured long term in a medium that stimulates WNT and MAPK (through EGF) signaling and inhibits TGFβ/activin A, HDAC and Rho Kinase. They are genetically stable and fulfill all four characteristics of first trimester trophoblast. They cannot be derived from term placentas, in keeping with the dramatic loss of proliferative potential of VCT after ~10 weeks gestation and the scarcity of VCT in term villi (Mayhew, 2014).  By modifying the culture conditions, hTSCs can be induced to differentiate along either syncytial or extravillous lineages. They also have clonal ability and one clone can generate both SCT and EVT, providing the first solid evidence of bipotentiality of hTSCs, a subject of ongoing debate (Baczyk et al., 2006; Haider et al., 2016; James et al., 2005; Lee et al., 2018). Comparison of the transcriptomes of hTSCs and first trimester trophoblast shows close similarity to VCT. However, the exact anatomical location of hTSCs in vivo in both the early placenta and the TE is still unclear. Likewise, while mouse TSCs can be derived from both the TE and the chorion prior to E11.5 and can be differentiated to all trophoblast populations, further investigation is needed to understand which murine trophoblast population they resemble in vivo and how they relate to human TSCs (Natale et al., 2017; Tanaka et al., 1998).  ScRNA-sequencing has now been performed on the mouse mid-gestation placenta and on human term placenta as well as the placenta early in its development (Liu et al., 2018; Nelson et al., 2016; Pavličev et al., 2017; Suryawanshi et al., 2018; Vento-Tormo et al., 2018). These studies may help elucidate the identities of the various trophoblast culture systems and their relation to trophoblast in vivo. 
hTSCs lines grow as a monolayer and therefore cannot recapitulate the complex branching morphology of early placental villi.  Recently, 3D cultures of human trophoblast cells, termed trophoblast organoids, that closely model the villous placenta and can be differentiated into EVT have been established (Haider et al., 2018a; Turco et al., 2018). Like other organoid culture systems these organoids are likely to be transformative in advancing our understanding of the physiology and disease of human tissues (Clevers, 2016; Huch and Koo, 2015). Trophoblast organoids grow for >1 year, are genetically stable and fulfill all trophoblast criteria (Turco et al., 2018). They also secrete placental hormones and proteins that alter maternal metabolism, appetite, and preparation for lactation. The ability to biobank hTSC cells/organoids from patients with a range of possible pregnancy problems also offers great potential. We anticipate these trophoblast culture systems can be used to address many questions: dissecting the genetic and epigenetic mechanisms underlying the identity of trophoblast lineages, SCT and EVT differentiation, and regulation of HLA expression. Furthermore, it will be possible to test the role of many genes directly in hTSCs by knock-down or knockout approaches (siRNA or gene editing with Crispr/Cas9).

Bioengineering-based approaches
Although hTSCs and organoids represent a major step forward in studying human trophoblast in vitro, there are several limitations; they model only the trophoblast component of the placenta and are heterogenous. Furthermore, because other cellular components of the placenta play an important role in regulating their development and function, future work is necessary to build more complex models. Microfluidics approaches that have been previously used to model human placental functions such as transport and invasion have shown promise (Abbas et al., 2017; Lee et al., 2016d). More recently, a variety of bioengineering systems such as the use of biomimetic scaffolds and synthetic hydrogels are being implemented for other organoid systems to generate improved tissue-like models (Takebe and Wells, 2019). These approaches have the added advantage of providing mechanical and signaling cues that further control cell behaviour and function whilst improving reproducibility (Yin et al., 2016). These systems could be adapted to study the interaction of trophoblast with placental stromal components, maternal cells such as glands or uterine NK cells to investigate the maternal-fetal dialogue of early pregnancy. For example, our long-term organoid culture system of endometrial glands will provide a tool to study the effect of glands on trophoblast and also provides an in vitro system to study glandular function in women with implantation failure (Turco et al., 2017).

Molecular mechanisms underpinning human placental development
Trophoblast cells have many unique features that set them apart from all other cell types including global hypomethylation, differential expression of microRNAs, unusual patterns of expression of HLA molecules, and expression of endogenous retroviral products (Macaulay et al., 2017; Sadovsky et al., 2015). Imprinted genes, preferentially expressed from one parental allele, are also important in placental development and, out of the 92 human imprinted genes, 75 are expressed in the placenta (Monk, 2015). The C19MC cluster, which encodes microRNAs, is paternally expressed in trophoblast. Although these miRNAs are expressed in hESCs, expression is much higher in trophoblast (Lee et al., 2016c; Malnou et al., 2019; Noguer-Dance et al., 2010). Apart from the C19MC cluster, several other genes that are involved in reproduction are located on chromosome 19q13.4 (Moffett and Colucci, 2015). These include choriogonadotropin subunit beta (CGB), pregnancy-specific glycoproteins (PSGs), killer-cell immunoglobulin-like receptors (KIR), leukocyte immunoglobulin-like receptors (LILR) and Nucleotide-binding oligomerization domain, Leucine rich Repeat and Pyrin domain containing family (NLRP). In humans, many X chromosome genes escape X inactivation in the placenta leading to transcriptional differences between female and male pregnancies that may explain the sex-based differences in pregnancy disorders (Gong et al., 2018; Moreira de Mello et al., 2010; Vatten and Skjaerven, 2004). There are also striking similarities between trophoblast and tumor cells. For instance, trophoblast cells exhibit invasive proclivities and an ability to avoid destructive inflammatory or immune responses, as well as widespread hypomethylation and focal hypermethylation at CpG islands including at promoters of tumour suppressor genes (Nordor et al., 2017).
Studies of the molecular changes occurring during human placental development have been mainly descriptive due to the lack of, until recently, long-term, genetically normal human trophoblast cell lines with which to perform functional studies. Nonetheless, these studies have provided insights into the molecular factors that contribute to trophoblast development and placentation. Below, we discuss these studies, highlighting relevant mouse data and, when available, data in humans, with a focus on papers that have validated the work using primary trophoblast cells. If other in vitro tools were used, this is specified. 

Establishment of the trophoblast lineage 
In mice, a hierarchy of transcription factors (TFs) drives TE lineage commitment. This process begins when Hippo signalling upregulates Tead4 in a subset of cells at the morula stage, which then drives Cdx2 expression in the future TE (Nishioka et al., 2009; Yagi et al., 2007). Tcfap2c is already expressed at the 8-cell stage and also regulates Cdx2 expression by binding to its enhancer (Cao et al., 2015). Cdx2 represses Oct4 to maintain its own expression whilst Gata2/Gata3 act in parallel to ensure trophoblast development (Home et al., 2017; Ralston et al., 2010; Strumpf et al., 2005). The identity of the trophoblast lineage is locked in place through the epigenetic regulation of Elf5, whose expression is reinforced by a positive feedback loop involving Cdx2 and Eomes (Ng et al., 2008). 
In human embryos, the timing and expression pattern of these TFs is different, suggesting other regulatory mechanisms are already in place from the earliest stage of TE specification. In mice, there is clear differential expression of Oct4 and Cdx2 in the ICM and TE, respectively, whilst in humans, lineage segregation between the ICM and TE occurs later in development. OCT4 is still expressed in TE until day 6 whilst CDX2 is only expressed at the blastocyst stage (Blakeley et al., 2015; Boroviak et al., 2018; Niakan and Eggan, 2013). Some ICM cells even retain TE identity at day 7 (Petropoulos et al., 2016; Stirparo et al., 2018). Thus, there seems to be more plasticity in the human TE lineage up to implantation. In a, pioneering study of gene editing of human embryos by CRISPR/Cas9, deletion of OCT4 at the diploid zygote stage compromised the development of both the ICM and the TE, highlighting the molecular differences between humans and mice on these early fate decisions (Fogarty et al., 2017).

VCT and CCCs
The molecular events occurring between implantation and villous formation in humans are obviously still a black box. Presumably, trophoblast populations arise from the polar TE as these are the cells that initially implant. VCT is the proliferative compartment of the placenta and   
expresses the trophoblast TFs found in mouse TSCs GATA2, GATA3, TFAP2C/A and TEAD4 (but not EOMES) are (Mirkovic et al., 2015; Soncin et al., 2018). Indeed, four of these factors, GATA2/3 and TFAP2A/C can induce cells purported to be of the trophoblast lineage in human pluripotent stem cells (Krendl et al., 2017). In humans, ELF5, whose promoter is hypomethylated, is expressed in VCT, similar to mouse (Hemberger et al., 2010b; Lee et al., 2016a). Although the ELF5 promoter remains hypomethylated in EVT, no ELF5 protein is present so other mechanisms must regulate its expression. TP63, a TF characteristic of epithelial stem cells, is also widely expressed in the early first trimester VCT all the way to term (Lee et al., 2007). A proportion of TP63+ cells express also CDX2 close to the chorionic plate (Horii et al., 2016; Li et al., 2014). CDX2 expression is then downregulated in VCT throughout the bulk of the placenta during the first trimester, apart from those close to the chorionic plate, where residual expression is seen (Soncin et al., 2018). Notably, hTSCs lack CDX2 expression, questioning whether this is a marker of trophoblast stem cells in the human placenta. 
VCT express a range of surface markers that distintinguish them from other trophoblast populations such as EGFR, cMET and specific members of the Wnt family (Jokhi et al., 1994; Kauma et al., 1997; Sonderegger et al., 2007). The importance of these signalling pathways for their proliferation has been confirmed by the isolation of proliferative trophoblast (Haider et al., 2018b; Okae et al., 2018; Turco et al., 2018).   Proliferative cells are also present in CCCs early in the first trimester and these gradually decrease in number and are mostly localised at the base of CCCs by ~12 weeks. This ‘generative niche’  was noticed >50 years ago and more recently trophoblast in this location is shown to have a distinct transcriptome compared to VCT and EVT, expressing Notch1, ITGA2 and CD31 (Haider et al., 2014; Lee et al., 2018; Pattillo et al., 1968). Notch1 expression becomes restricted to the base of the CCC by the end of the first trimester (Haider et al., 2016). Whether cells in this niche generate EVT alone or both EVT and VCT is unknown. 

SCT differentiation
SCT covering the villi is terminally differentiated and SCT fragments are continuously shed into the maternal circulation. Placental explants, primary trophoblast cells that can fuse in vitro and the BeWo choriocarcinoma line have been used to study the process of SCT regeneration from the underlying VCT. These studies have revealed human endogenous retroviral proteins (HERVs), such as SYNCYTIN-1 (HERV-W env) as key regulators of this process (Mi et al., 2000). Retroviral elements are viral gene remnants that have been integrated into the human genome and co-opted as either promoters or enhancers and, in the case of placenta, encode retroviral proteins. Around 8% of the human genome contains HERVs (McPherson et al., 2001). The placenta is a particularly favorable site for HERV expression and different species have co-opted different retroviral families for the same function (Frendo et al., 2003a; Harris, 1991). 
A key step in syncytialization is the acquisition of fusion competence, which requires VCT to exit the cell cycle. Whether the signal that triggers this event originates from SCT or VCT, and if the same process occurs after syncytial damage, is unknown. VCT cells upregulate fusion genes, followed by disintegration of cell membranes and incorporation of the cytoplasm into the SCT. Using choriocarcinoma lines, a critical event occurring during this process was identified as an increase in cyclic AMP through protein kinase A (PKA) signaling, which  upregulates GCM1 expression and in turn induces expression of the fusion proteins Syncytin 1 and 2 (Knerr et al., 2005; Liang et al., 2010). The final step in syncytialization requires fusion of the cell membranes and intermingling of the cellular contents (Gerbaud and Pidoux, 2015). 
Syncytins use specific receptors, ASCT2 (for SYNCYTIN-1) and MFSD2 (for SYNCYTIN-2), to allow fusion of VCT to SCT (Esnault et al., 2008; Hayward et al., 2007). ASCT2 is restricted to VCT whilst MFSD2 is expressed on SCT. Furthermore, SCT produces hCG which, after binding to the LH-CG receptor, induces cyclic AMP signaling and thereby promotes the upregulation of syncytial genes as well as that of hCG (Pidoux et al., 2007; Shi et al., 1993). Thus, the SCT itself reinforces the process in a positive feedback loop. Activation of PKA signalling through hCG is also coupled to phosphorylation of Connexin 43 (Cx43) through Ezrin, which induces the opening of gap junctions and transfer of fusogenic signals between VCT and SCT (Frendo et al., 2003b; Pidoux et al., 2014). Several other factors may also be involved in syncytialization, such as the MAPK signaling pathway, acting through EGF and EGFR, GM-CSF signaling, and Activin-A signaling, which acts through SMAD4 (Garcia-Lloret et al., 1994; Gerbaud et al., 2011; Morrish et al., 1987). On the other hand, TGFβ produced by SCT seems to provide a signal that balances the syncytialization process by inhibiting fusion (Morrish et al., 1991). Interferons induced by infection act to prevent infection of other neighboring cells. One interferon-stimulated gene, IFITM3, inhibits syncytin-mediated fusion of trophoblast into SCT and this may cause pregnancy failure in infections such as CMV or rubella  (Buchrieser et al., 2019).

EVT differentiation 
Global transcriptomic studies show clear differences between VCT and EVT (Apps et al., 2011; Lee et al., 2018a; Tilburgs et al., 2015). When EVT migrate out from the CCCs into the decidua, features characteristic of EMT are observed. These include: a loss of epithelial characteristics, including downregulation of E-cadherin and tight junction proteins such as ZO-1; a change in apical-basal polarity; a switch in integrin expression, from laminin-binding integrin α6β4 to fibronectin-binding integrins α1β1 and α1β5; an increase in cell size; and an accumulation of glycogen (Damsky et al., 1992; Damsky et al., 1994; Marzioni et al., 2001). EVT also upregulate endothelial markers such as the laminin α4 receptor MCAM, VE-cadherin and the metalloproteinases MMP-2, MMP-3 and MMP-9 (Fisher, 1989; Xu et al., 2000; Zhou et al., 1997). A defining feature of EVT differentiation is upregulation of the non-classical MHC Class I molecule, HLA-G as well as HLA-C (King et al., 1996; King et al., 2000b; Kovats et al., 1990). The expression of several growth factor receptors also changes: EGFR, cMET (the receptor for HGF), prolactin receptor (PRLR) and the BMP receptor BMPR1A are downregulated, while ERBB2 is upregulated (Jokhi et al., 1994; Kauma et al., 1999; Ladines-Llave et al., 2013; Stefanoska et al., 2013; Tilburgs et al., 2015). All of these changes are accompanied by loss of proliferation, as assessed by Ki67 expression, and a change in expression of cell cycle regulators (Chan et al., 1999; Genbacev et al., 2000). EVT differentiation is also characterized by endoreduplication resulting in tetraploid cells (Velicky et al., 2018). 
EVT cells themselves produce several proteins and hormones: TGFβ1, follistatin and hyper-glycolsylated hCG. Activin-A has a stimulatory effect on the differentiation on EVT differentiation in placental explants, in complete constrast to the mouse where it maintains trophoblast stem cell proliferation (Caniggia et al., 1997; Erlebacher et al., 2004).  
The endpoint of iEVT differentiation is fusion to placental bed giant cells. These large multinucleated cells produce human placental lactogen and are present deep in the decidua basalis and the inner third of the myometrium, the normal limit of iEVT infiltration (al-Lamki et al., 1999; Boyd and Hamilton, 1970; Brosens et al., 1967; Kurman et al., 1984). The signals and TFs driving EVT differentiation into either eEVT or iEVT are unknown. The cells in the EVT plugs in the spiral arteries are morphologically quite different than iEVT (Pijnenborg, 1996). Only two clear phenotypic differences have been defined so far: eEVT express CD56 (NCAM) and, because occasional CD56+ cells appear within the shell overlying the openings of the arteries, it is thought that signals from maternal blood may stimulate eEVT differentiation (Burrows et al., 1994; Kam et al., 1999). In contrast, iEVT specifically express Placenta-specific protein 8, PLAC8, which is known to be involved in EMT (Chang et al., 2018).
Due to the presence of eEVT plugs in the spiral arteries, the conceptus is in a physiologically low oxygen environment before ~10 weeks gestation; this is not be confused with hypoxia, which refers to a non-physiological state of insufficient oxygen. The metabolic consequences of this are a reliance on glycolysis, preservation of carbon skeletons used for synthesis of cellular components, and protection from damage from free radicals (Burton et al., 2017). The subsequent dissolution of the eEVT plugs (at ~10 weeks) and the onset of the maternal circulation correlate with changes in oxygen levels, from 2.5% to around 8% (Jauniaux et al., 2000; Rodesch et al., 1992). The onset of circulation occurs more in the centre than at the periphery of the placentation site because of the more pronounced trophoblast invasion and arterial transformation centrally. The villi regress at the periphery resulting in formation of the chorion laeve (fetal membranes composed of amnion and chorion superimposed on decidua parietalis) and the definitive placenta (Burton, 2009).  Disturbance of this orderly process can result in miscarriage and abnormal placental membranes, predisposing to preterm labour and placental abruption (Burton and Jauniaux, 2017; Jauniaux et al., 2000). The hypoxic environment of the first few weeks of gestation might induce EVT differentiation through HIF1A as more HLA-G+ EVT are generated in vitro when cultured in 2% O2 with upregulation of the imprinted bHLH factor, ASCL2, a WNT target involved in EMT (Wakeland et al., 2017).

Regulation of placental development by the decidua 
The human placenta develops within the endometrium, which is  transformed into decidua during pregnancy under the influence of progesterone secreted by the corpus luteum (Gellersen and Brosens, 2014). The endometrium is highly dynamic and undergoes cyclical regeneration, differentiation and shedding during the menstrual cycle under the control of hormones of the ovarian-pituitary axis. In humans, features of decidualisation (pre-decidual change) are seen after the mid-secretory phase of the menstrual cycle and begin around the spiral arteries (Kurman, 2002). Following implantation, proper decidualisation of the endometrium then plays a key role in the development of the placenta and is likely to involve all the major cellular elements of the endometrium: glands, vessels, stromal cells and immune cells. 

Endometrial glands and stromal cells
The endometrial glands play a key role in embryo implantation and development of the placenta in mice and domestic species (Spencer et al., 2019). Glands become hypersecretory in early pregnancy with a characteristic appearance known as the Arias-Stella reaction (Arias-Stella, 1954). In humans, the conceptus depends on glandular secretions as the source of histotrophic nutrition during the early weeks of pregnancy, when the endovascular plugs only allow seepage of maternal blood into the intervillous space (Burton et al., 2002; Burton et al., 2007). 
	The stromal cells of the endometrium also produce a wide range of growth factors that stimulate the glands. As they decidualise, the stromal cells secrete a rim of basement membrane proteins, fibronectin and laminin, which provides a scaffold for the EVT to move through (Aplin et al., 1988). Exactly what defines the characteristics of a receptive decidualised endometrium that will support the developing placenta is still unclear (Koot et al., 2016; Young, 2017). This is an important question because evidence to suggest that defective decidualisation is an antecedent of  pregnancy disorders is growing (Conrad et al., 2017; Garrido-Gomez et al., 2017). Maternal nutrition, extremes of reproductive life, low or high BMI, endocrine disorders (e.g. thyroid disease), and diabetes, can all affect the cycling of a healthy endometrium but it is unclear how these affect decidualisation and receptivity. 

Uterine leukocytes and other immune cells
The dominant immune cells in the first trimester are a type of innate lymphoid cell known as uterine Natural Killer (uNK) cells (Bulmer and Lash, 2015; Moffett and Colucci, 2015; Vacca et al., 2019). These cells make up ~70% of immune cells in the uterine environment while macrophages account for ~20% and T cells ~10%. B cells and mast cells are virtually absent, and neutrophils are also sparse (Vento-Tormo et al., 2018). This is therefore an unusual immune environment where cells of the innate rather than the adaptive (T and B cells) immune system predominate. Our recent scRNA-seq study of first trimester decidual cells defines three sub-populations of uNK all with specific immunomodulatory signatures and expressing a range of receptors for EVT (Vento-Tormo et al., 2018). Their functional roles await investigation.
	As mentioned, EVT have been compared to tumour cells due to their invasive properties. However, unlike tumour cells, the behavior of trophoblast cells within the decidual microenvironment is controlled. Accordingly, necrosis of the decidua is not seen as EVT migrate deep into the tissue, apart from the enigmatic Nitabuch’s layer, a thin rim of fibrinoid tissue subjacent to the shell at the maternal-fetal boundary (Boyd and Hamilton, 1970). Furthermore, although placentation is often considered as an inflammatory process (Chavan et al., 2017), the defining classical features of inflammation (neutrophil infiltration followed by influx of inflammatory cells followed by granulation tissue - capillary angiogenesis and fibrosis) are always absent.  Our scRNA-seq study predicts several mechanisms that mean no inflammatory or adaptive immune responses are likely to occur in this specialised environment (Vento-Tormo et al., 2018).  

Abnormal placental development and pregnancy complications
Many complications of pregnancy have their origins in abnormal development of the placenta in the first trimester (Smith, 2010). These include pre-eclampsia, fetal growth restriction (FGR), unexplained stillbirth, placental abruption and preterm labour; these complications are known collectively as the Great Obstetric Syndromes (GOS) (Brosens et al., 2011). These conditions are responsible for a high proportion of maternal and neonatal morbidity and mortality seen in all populations but particularly in sub-Saharan Africa (Graham et al., 2016).  
Defective trophoblast invasion is the ultimate cause of the GOS.  Trophoblast cells invade into the decidua to gain access to the maternal blood supply and successful EVT transformation of ~30-40 spiral arteries deep into the myometrium is essential for normal fetal growth and development (Burton et al., 2009; Collins et al., 2012). If the arteries are not sufficiently converted and retain their contractile media, there is disordered perfusion of blood flow into the intervillous space. This, together with an inadequate supply of nutrients and oxygen reduces the progressive branching of the villous tree as gestation proceeds, reducing the surface area needed for exchange with the possible outcome of FGR and stillbirth. In addition, if the process of regression of the chorion frondiosum to form the chorion laeve does not occur correctly, the chorionic membranes can separate prematurely, resulting in placental abruption or preterm labour. Pre-eclampsia results from the release of products from the poorly perfused and stressed placenta into the maternal circulation, triggering a systemic endothelial disorder (Burton et al., 2019; Roberts and Redman, 1993). Thus, the exact clinical outcome of defective trophoblast invasion depends on the extent of arterial invasion and the number of arteries invaded.  
Because deep trophoblast invasion into the uterus is a feature seen only in humans and great apes, defective transformation of arteries has been hard to characterize and hence diagnose early in pregnancy. A number of clinical measurements are being developed to overcome this, such as uterine artery Doppler velocimetry, which measures the resistance to blood flow and is thus an indirect readout of the degree of spiral artery remodeling (O’Gorman et al., 2017). As EVT move deeper, expression of pregnancy-associated plasma protein-A (PAPPA-A) increases, and measurement of this protein in maternal serum in the first trimester is a useful predictor of GOS (Gaccioli et al., 2018). The ratio of soluble fms-like tyrosine kinases 1 (sflt-1) to placental growth factor (PlGF) is elevated in women before they develop the clinical symptoms of pre-eclampsia  (Zeisler et al., 2016). A low ratio can be used to predict the women who will not go on to develop the syndrome in the following week. Another approach is to screen maternal blood for biomarkers that reflect placental function.  These include miRNAs, exosomes, free DNA, proteins and short non-coding RNAs (Barchitta et al., 2017; Gaccioli et al., 2018; Rolnik et al., 2018; Tsang et al., 2017; Yoffe et al., 2018).  The benefits of these screening tests in low risk populations are still not obvious, particularly as the only intervention possible at present is early delivery with obvious risk to the neonate; some reports suggest that these screening tests may actually be harmful (Monier et al., 2015).  
Since defective trophoblast invasion is the ultimate cause of the GOS, an important is to understand how EVT invasion into the uterus is regulated. A role for decidua in preventing placental cells from invading too far is clear from clinical reports where the placenta implants on a site where decidua is deficient or absent (Jauniaux et al., 2018). This can occur in the lower segment of the uterus close to the cervix or over a caesarean section scar from a previous pregnancy. In these situations, EVT penetrate into the myometrium and destroy the smooth muscle cells with a similar ‘fibrinoid’ appearance seen whentrophoblast transforms the spiral arterial media.  Furthermore, fusion to placental bed giant cells, which is normally observed at the end of EVT migration, is drastically reduced (Hannon et al., 2012).  Together, these findings highlight that the territorial boundary between placenta and mother needs to be finely controlled and that this balancing act is mediated by the decidua.  
Features of pre-eclampsia that suggest maternal-fetal immune interactions also play an important role in balancing EVT invasion are memory and specificity (Wikström et al., 2012). Immune memory refers to the ability of immune cells to ‘remember’ encounters with specific pathogens and subsequently respond differently to the same pathogen (Sun et al., 2014). The incidence of pre-eclampsia is highest in first pregnancies and then falls if the second pregnancy is with the same partner. That there are partner-specific effects in pre-eclampsia is seen in pregnancies in women who change partners (Wikström et al., 2012).  These epidemiological findings led us to explore the interactions between KIR receptors expressed by one of the uNK sub-populations that amass around the invading EVT, which express the KIR ligands, HLA-C molecules.  Both the maternal KIR and fetal HLA-C ligands are highly polymorphic and particular KIR/HLA-C combinations are found in pregnancies complicated by pre-eclampsia and FGR (Moffett and Colucci, 2015).  Exactly how these genetic findings translate into functions of uNK cells is still not unknown; the uNK cells might affect EVT invasion directly or act indirectly on the arteries or glands. 

Conclusions and future directions
Although much has been learnt recently, there are still many questions to answer about human placental development: the specification of the TE lineage, the identity of TSCs, differentiation into the two main lineages, and the impact of the maternal environment on both VCT and EVT. Recent studies have revealed specific and unique features of human trophoblast and the decidual microenvironment.  The development of the placenta is complex and challenging to study. However, new techniques are now being used to study human placental development to overcome these challenges. These include scRNA-seq, spatial transcriptomics, epigenetics, miRNA expression and organoid cultures (Figure 3). This is an exciting time for placental research as we begin to address the fundamental question on how the human placenta develops in normal and abnormal pregnancies. xxx 

The NICHD’s Human Placenta Project (HPP) is a collaborative research effort to understand the role of the placenta in health and disease.
https://www.nichd.nih.gov/research/supported/HPP/default.
Descriptions of the early stages of human pregnancy are available in classic textbooks (Boyd; Benrniscke).  Specimens are held in the Centre for Trophoblast Research in the University of Cambridge (www.trophoblast.cam.ac.uk).  Applications to view these in person can be made to the CTR.

Acknowledgements
The authors thank Graham Burton, Charlie Loke and Jenny Nichols for helpful discussions. We thank Philip M. Ball for the figures. We are grateful for funding from the Wellcome Trust, Medical Research Council, Centre for Trophoblast Research and the Royal Society.  MYT is a Royal Society Dorothy Hodgkin Fellow. 

References

Abbas, Y., Melati, O. C., J., P. W., Lucy, G., Lydia, F., Andrew, S., Roger, K., Ashley, M. and L., O. M. (2017). A microfluidics assay to study invasion of human placental trophoblast cells. J. R. Soc. Interface 14, 20170131.
Abou-Kheir, W., Barrak, J., Hadadeh, O. and Daoud, G. (2017). HTR-8/SVneo cell line contains a mixed population of cells. Placenta 50, 1–7.
al-Lamki, R. S., Skepper, J. N. and Burton, G. J. (1999). Are human placental bed giant cells merely aggregates of small mononuclear trophoblast cells? An ultrastructural and immunocytochemical study. Hum. Reprod. 14, 496–504.
Amita, M., Adachi, K., Alexenko, A. P., Sinha, S., Schust, D. J., Schulz, L. C., Roberts, R. M. and Ezashi, T. (2013). Complete and unidirectional conversion of human embryonic stem cells to trophoblast by BMP4. Proc. Natl. Acad. Sci. 110, E1212–E1221.
Aplin, J. D., Charlton, A. K. and Ayad, S. (1988). An immunohistochemical study of human endometrial extracellular matrix during the menstrual cycle and first trimester of pregnancy. Cell Tissue Res. 253, 231–40.
Apps, R., Gardner, L., Sharkey, A. M., Holmes, N. and Moffett, A. (2007). A homodimeric complex of HLA-G on normal trophoblast cells modulates antigen-presenting cells via LILRB1. Eur. J. Immunol. 37, 1924–37.
Apps, R., Murphy, S. P., Fernando, R., Gardner, L., Ahad, T. and Moffett, A. (2009). Human leucocyte antigen (HLA) expression of primary trophoblast cells and placental cell lines, determined using single antigen beads to characterize allotype specificities of anti-HLA antibodies. Immunology 127, 26–39.
Apps, R., Sharkey,  a., Gardner, L., Male, V., Trotter, M., Miller, N., North, R., Founds, S. and Moffett,  a. (2011). Genome-wide expression profile of first trimester villous and extravillous human trophoblast cells. Placenta 32, 33–43.
Arias-Stella, J. (1954). Atypical endometrial changes associated with the presence of chorionic tissue. AMA Arch Pathol 52(2), 112–28.
Baczyk, D., Dunk, C., Huppertz, B., Maxwell, C., Reister, F., Giannoulias, D. and Kingdom, J. C. P. (2006). Bi-potential behaviour of cytotrophoblasts in first trimester chorionic villi. Placenta 27, 367–374.
Barchitta, M., Maugeri, A., Quattrocchi, A., Agrifoglio, O. and Agodi, A. (2017). The Role of miRNAs as Biomarkers for Pregnancy Outcomes: A Comprehensive Review. Int. J. Genomics 2017, 1–11.
Barker, D. J. (1995). The fetal and infant origins of disease. Eur. J. Clin. Invest. 25, 457–63.
Benirschke, K., Burton, G. J. and Baergen, R. N. (2012). Pathology of the Human Placenta. 6th ed. Berlin: Springer.
Bernardo, A. S., Faial, T., Gardner, L., Niakan, K. K., Ortmann, D., Senner, C. E., Callery, E. M., Trotter, M. W., Hemberger, M., Smith, J. C., et al. (2011). Article BRACHYURY and CDX2 Mediate BMP-Induced Differentiation of Human and Mouse Pluripotent Stem Cells into Embryonic and Extraembryonic Lineages. Stem Cell 9, 144–155.
Blakeley, P., Fogarty, N. M. E., del Valle, I., Wamaitha, S. E., Hu, T. X., Elder, K., Snell, P., Christie, L., Robson, P. and Niakan, K. K. (2015). Defining the three cell lineages of the human blastocyst by single-cell RNA-seq. Development 142, 3613–3613.
Boroviak, T., Stirparo, G. G., Dietmann, S., Hernando-Herraez, I., Mohammed, H., Reik, W., Smith, A., Sasaki, E., Nichols, J. and Bertone, P. (2018). Single cell transcriptome analysis of human, marmoset and mouse embryos reveals common and divergent features of preimplantation development. Development 145, dev167833.
Boss, A. L., Chamley, L. W. and James, J. L. (2018). Placental formation in early pregnancy: how is the centre of the placenta made? Hum. Reprod. Update 24, 750–760.
Boyd, J. D. and Hamilton, W. J. (1970). The Human Placenta. w. Heffer & Sons LTD.
Brosens, I., Robertson, W. B. and Dixon, H. G. (1967). The physiological response of the vessels of the placental bed to normal pregnancy. J. Pathol. Bacteriol. 93, 569–579.
Brosens, I., Pijnenborg, R., Vercruysse, L. and Romero, R. (2011). The “Great Obstetrical Syndromes” are associated with disorders of deep placentation. Am. J. Obstet. Gynecol. 204, 193–201.
Buchrieser, J., Degrelle, S. A., Couderc, T., Nevers, Q., Disson, O., Manet, C., Donahue, D. A., Porrot, F., Hillion, K.-H., Perthame, E., et al. (2019). IFITM proteins inhibit placental syncytiotrophoblast formation and promote fetal demise. Science 365, 176–180.
Bulmer, J. N. and Lash, G. E. (2015). The Role of Uterine NK Cells in Normal Reproduction and Reproductive Disorders.pp. 95–126. Springer, Cham.
Burrows, T. D., King, A. and Loke, Y. W. (1994). Expression of adhesion molecules by endovascular trophoblast and decidual endothelial cells: Implications for vascular invasion during implantation. Placenta 15, 21–33.
Burton, G. J. (1987). The fine structure of the human placental villus as revealed by scanning electron microscopy. Scanning Microsc. 1, 1811–28.
Burton, G. J. (2009). Oxygen, the Janus gas; its effects on human placental development and function. J. Anat. 215, 27–35.
Burton, G. J. and Jauniaux, E. (2017). The cytotrophoblastic shell and complications of pregnancy. Placenta 60, 134–139.
Burton, G. J., Jauniaux, E. and Watson, A. L. (1999). Maternal arterial connections to the placental intervillous space during the first trimester of human pregnancy: the Boyd collection revisited. Am. J. Obstet. Gynecol. 181, 718–24.
Burton, G. J., Watson, A. L., Hempstock, J., Skepper, J. N., Jauniaux, E., Cb, C. and Kingdom, U. (2002). Uterine Glands Provide Histiotrophic Nutrition for the Human Fetus during the First Trimester of Pregnancy. 87, 2954–2959.
Burton, G. J., Jauniaux, E. and Charnock-Jones, D. S. (2007). Human early placental development: potential roles of the endometrial glands. Placenta 28 Suppl A, S64-9.
Burton, G. J., Woods, A. W., Jauniaux, E. and Kingdom, J. C. P. (2009). Rheological and Physiological Consequences of Conversion of the Maternal Spiral Arteries for Uteroplacental Blood Flow during Human Pregnancy. Placenta 30, 473–482.
Burton, G. J., Jauniaux, E. and Murray, A. J. (2017). Oxygen and placental development; parallels and differences with tumour biology. Placenta 56, 14–18.
Burton, G. J., Redman, C. W., Roberts, J. M. and Moffett, A. (2019). Pre-eclampsia: pathophysiology and clinical implications. BMJ 366, l2381.
Caniggia, I., Lye, S. J. and Cross, J. C. (1997). Activin Is a Local Regulator of Human Cytotrophoblast Cell Differentiation 1. Endocrinology 138, 3976–3986.
Cao, Z., Carey, T. S., Ganguly, A., Wilson, C. A., Paul, S. and Knott, J. G. (2015). Transcription factor AP-2  induces early Cdx2 expression and represses HIPPO signaling to specify the trophectoderm lineage. Development 142, 1606–1615.
Carter, A. M. (2011). Comparative studies of placentation and immunology in non-human primates suggest a scenario for the evolution of deep trophoblast invasion and an explanation for human pregnancy disorders. REPRODUCTION 141, 391–396.
Carter, A. M. and Enders, A. C. (2004). Comparative aspects of trophoblast development and placentation. Reprod. Biol. Endocrinol. 2, 46.
Carter, A. M. and Enders, A. C. (2013). The Evolution of Epitheliochorial Placentation. Annu. Rev. Anim. Biosci. 1, 443–467.
Carter, A. M. and Pijnenborg, R. (2011). Evolution of invasive placentation with special reference to non-human primates. Best Pract. Res. Clin. Obstet. Gynaecol. 25, 249–257.
Castellucci, M., Celona, A., Bartels, H., Steininger, B., Benedetto, V. and Kaufmann, P. (1987). Mitosis of the Hofbauer cell: possible implications for a fetal macrophage. Placenta 8, 65–76.
Castellucci, M., Kosanke, G., Verdenelli, F., Huppertz, B. and Kaufmann, P. (2000). Villous sprouting : fundamental mechanisms of human placental development. 6,.
Chan, C. C. W., Lao, T. T. and Cheung, A. N. Y. (1999). Apoptotic and Proliferative Activities in First Trimester Placentae. Placenta 20, 223–227.
Chang, W.-L., Liu, Y.-W., Dang, Y.-L., Jiang, X.-X., Xu, H., Huang, X., Wang, Y.-L., Wang, H., Zhu, C., Xue, L.-Q., et al. (2018). PLAC8, a new marker for human interstitial extravillous trophoblast cells, promotes their invasion and migration. Development 145, dev148932.
Chavan, A. R., Griffith, O. W. and Wagner, G. P. (2017). The inflammation paradox in the evolution of mammalian pregnancy: turning a foe into a friend. Curr. Opin. Genet. Dev. 47, 24–32.
Clevers, H. (2016). Modeling Development and Disease with Organoids. Cell 165, 1586–1597.
Collins, S. L., Birks, J. S., Stevenson, G. N., Papageorghiou, A. T., Noble, J. A. and Impey, L. (2012). Original Paper. Ultrasound Obstet. Gynecol. 40, 171–178.
Conrad, K. P., Rabaglino, M. B. and Post Uiterweer, E. D. (2017). Emerging role for dysregulated decidualization in the genesis of preeclampsia. Placenta 60, 119–129.
Damsky, C. H., Fitzgerald, M. L. and Fisher, S. J. (1992). Distribution Patterns of Extracellular Matrix Components and Adhesion Receptors Are Intricately Modulated during First Trimester Cytotrophoblast Differentiation along the Invasive Pathway , In Vivo. 89, 210–222.
Damsky, C. H., Librach, C., Lim, K., Fitzgerald, M. L., Mcmaster, M. T., Janatpour, M., Zhou, Y., Logan, S. K. and Fisher, S. J. (1994). Integrin switching regulates normal trophoblast invasion. 3666, 3657–3666.
Deglincerti, A., Croft, G. F., Pietila, L. N., Zernicka-Goetz, M., Siggia, E. D. and Brivanlou, A. H. (2016). Self-organization of the in vitro attached human embryo. Nature 533, 251.
Dempsey, E. W. (1972). The development of capillaries in the villi of early human placentas. Am. J. Anat. 134, 221–237.
Erlebacher, A., Price, K. A. and Glimcher, L. H. (2004). Maintenance of mouse trophoblast stem cell proliferation by TGF-beta/activin. Dev. Biol. 275, 158–69.
Esnault, C., Priet, S., Ribet, D., Vernochet, C., Bruls, T., Lavialle, C., Weissenbach, J. and Heidmann, T. (2008). A placenta-specific receptor for the fusogenic, endogenous retrovirus-derived, human syncytin-2. Proc. Natl. Acad. Sci. U. S. A. 105, 17532–7.
Feng, H. C., Choy, M. Y., Deng, W., Wong, H. L., Lau, W. M., Cheung, A. N. Y., Ngan, H. Y. S. and Tsao, S. W. (2005). Establishment and characterization of a human first-trimester extravillous trophoblast cell line (TEV-1). J. Soc. Gynecol. Investig. 12, e21-32.
Fisher, S. J. (1989). Adhesive and degradative properties of human placental cytotrophoblast cells in vitro. J. Cell Biol. 109, 891–902.
Fogarty, N. M. E., McCarthy, A., Snijders, K. E., Powell, B. E., Kubikova, N., Blakeley, P., Lea, R., Elder, K., Wamaitha, S. E., Kim, D., et al. (2017). Genome editing reveals a role for OCT4 in human embryogenesis. Nature 550, 67–73.
Frendo, J. L., Olivier, D., Cheynet, V., Blond, J. L., Bouton, O., Vidaud, M., Rabreau, M., Evain-Brion, D. and Mallet, F. (2003a). Direct involvement of HERV-W Env glycoprotein in human trophoblast cell fusion and differentiation. Mol Cell Biol 23, 3566–3574.
Frendo, J.-L., Cronier, L., Bertin, G., Guibourdenche, J., Vidaud, M., Evain-Brion, D. and Malassine, A. (2003b). Involvement of connexin 43 in human trophoblast cell fusion and differentiation. J. Cell Sci. 116, 3413–3421.
Gaccioli, F., Aye, I. L. M. H., Sovio, U., Charnock-Jones, D. S. and Smith, G. C. S. (2018). Screening for fetal growth restriction using fetal biometry combined with maternal biomarkers. Am. J. Obstet. Gynecol. 218, S725–S737.
Garcia-Lloret, M. I., Morrish, D. W., Wegmann, T. G., Honore, L., Turner, A. R. and Guilbert, L. J. (1994). Demonstration of functional cytokine-placental interactions: CSF-1 and GM-CSF stimulate human cytotrophoblast differentiation and peptide hormone secretion. Exp. Cell Res. 214, 46–54.
Garrido-Gomez, T., Dominguez, F., Quiñonero, A., Diaz-Gimeno, P., Kapidzic, M., Gormley, M., Ona, K., Padilla-Iserte, P., McMaster, M., Genbacev, O., et al. (2017). Defective decidualization during and after severe preeclampsia reveals a possible maternal contribution to the etiology. Proc. Natl. Acad. Sci. U. S. A. 114, E8468–E8477.
Gaunt, M. and Ockleford, C. D. (1986). Microinjection of human placenta. II: Biological application. Placenta 7, 325–31.
Gellersen, B. and Brosens, J. J. (2014). Cyclic Decidualization of the Human Endometrium in Reproductive Health and Failure. Endocr. Rev. 35, 851–905.
Genbacev, O., McMaster, M. T. and Fisher, S. J. (2000). A Repertoire of Cell Cycle Regulators Whose Expression Is Coordinated with Human Cytotrophoblast Differentiation. Am. J. Pathol. 157, 1337–1351.
Genbacev, O., Donne, M., Kapidzic, M., Gormley, M., Lamb, J., Gilmore, J., Larocque, N., Goldfien, G., Zdravkovic, T., McMaster, M. T., et al. (2011). Establishment of Human Trophoblast Progenitor Cell Lines from the Chorion. Stem Cells 29, N/A-N/A.
Genbacev, O., Larocque, N., Ona, K., Prakobphol, A., Garrido-Gomez, T., Kapidzic, M., Bárcena, A., Gormley, M. and Fisher, S. J. (2016). Integrin α4-positive human trophoblast progenitors: functional characterization and transcriptional regulation. Hum. Reprod. 31, 1300–14.
Georgiades, P., Ferguson-Smith, A. C. and Burton, G. J. (2002). Comparative Developmental Anatomy of the Murine and Human Definitive Placentae. Placenta 23, 3–19.
Gerbaud, P. and Pidoux, G. (2015). Review: An overview of molecular events occurring in human trophoblast fusion. Placenta 36, S35–S42.
Gerbaud, P., Pidoux, G., Guibourdenche, J., Pathirage, N., Costa, J. M., Badet, J., Frendo, J.-L., Murthi, P. and Evain-Brion, D. (2011). Mesenchymal activin-A overcomes defective human trisomy 21 trophoblast fusion. Endocrinology 152, 5017–28.
Gong, S., Sovio, U., Aye, I. L., Gaccioli, F., Dopierala, J., Johnson, M. D., Wood, A. M., Cook, E., Jenkins, B. J., Koulman, A., et al. (2018). Placental polyamine metabolism differs by fetal sex, fetal growth restriction, and preeclampsia. JCI insight 3,.
Graham, C. H., Hawley, T. S., Hawley, R. G., MacDougall, J. R., Kerbel, R. S., Khoo, N. and Lala, P. K. (1993). Establishment and characterization of first trimester human trophoblast cells with extended lifespan. Exp. Cell Res. 206, 204–11.
Graham, W., Woodd, S., Byass, P., Filippi, V., Gon, G., Virgo, S., Chou, D., Hounton, S., Lozano, R., Pattinson, R., et al. (2016). Diversity and divergence: the dynamic burden of poor maternal health. Lancet 388, 2164–2175.
Haider, S., Meinhardt, G., Velicky, P., Otti, G. R., Whitley, G., Fiala, C., Pollheimer, J. and Knofler, M. (2014). Notch signaling plays a critical role in motility and differentiation of human first-trimester cytotrophoblasts. Endocrinology 155, 263–274.
Haider, S., Meinhardt, G., Saleh, L., Fiala, C., Pollheimer, J. and Knofler, M. (2016). Notch1 controls development of the extravillous trophoblast lineage in the human placenta. Proc Natl Acad Sci U S A 113, E7710–E7719.
Haider, S., Meinhardt, G., Saleh, L., Kunihs, V., Gamperl, M., Kaindl, U., Ellinger, A., Burkard, T. R., Fiala, C., Pollheimer, J., et al. (2018a). Self-Renewing Trophoblast Organoids Recapitulate the Developmental Program of the Early Human Placenta. Stem cell reports 11, 537–551.
Haider, S., Meinhardt, G., Saleh, L., Kunihs, V., Gamperl, M., Kaindl, U., Ellinger, A., Burkard, T. R., Fiala, C., Pollheimer, J., et al. (2018b). Self-Renewing Trophoblast Organoids Recapitulate the Developmental Program of the Early Human Placenta. Stem Cell Reports 11, 537–551.
Hannon, T., Innes, B. A., Lash, G. E., Bulmer, J. N. and Robson, S. C. (2012). Effects of local decidua on trophoblast invasion and spiral artery remodeling in focal placenta creta – An immunohistochemical study. Placenta 33, 998–1004.
Harris, J. R. (1991). The evolution of placental mammals. FEBS Lett. 295, 3–4.
Hayward, M. D., G. Pötgens, A. J., Drewlo, S., Kaufmann, P. and J. Rasko, J. E. (2007). Distribution of human endogenous retrovirus type W receptor in normal human villous placenta. Pathology 39, 406–412.
Heazlewood, C. F., Sherrell, H., Ryan, J., Atkinson, K., Wells, C. A. and Fisk, N. M. (2014). High Incidence of Contaminating Maternal Cell Overgrowth in Human Placental Mesenchymal Stem/Stromal Cell Cultures: A Systematic Review. Stem Cells Transl. Med. 3, 1305–1311.
Hemberger, M., Udayashankar, R., Tesar, P., Moore, H. and Burton, G. J. (2010a). ELF5-enforced transcriptional networks define an epigenetically regulated trophoblast stem cell compartment in the human placenta. 19, 2456–2467.
Hemberger, M., Udayashankar, R., Tesar, P., Moore, H. and Burton, G. J. (2010b). ELF5-enforced transcriptional networks define an epigenetically regulated trophoblast stem cell compartment in the human placenta. Hum Mol Genet 19, 2456–2467.
Hertig, A. T., Rock, J. and Adams, E. C. (1956). A description of 34 human ova within the first 17 days of development. Am. J. Anat. 98, 435–93.
Hertz, R. (1959). Choriocarcinoma of women maintained in serial passage in hamster and rat. Proc. Soc. Exp. Biol. Med. 102, 77–81.
Home, P., Kumar, R. P., Ganguly, A., Saha, B., Milano-Foster, J., Bhattacharya, B., Ray, S., Gunewardena, S., Paul, A., Camper, S. A., et al. (2017). Genetic redundancy of GATA factors in the extraembryonic trophoblast lineage ensures the progression of preimplantation and postimplantation mammalian development. Development 144, 876–888.
Horii, M., Li, Y., Wakeland, A. K., Pizzo, D. P., Nelson, K. K., Sabatini, K., Laurent, L. C., Liu, Y. and Parast, M. M. (2016). Human pluripotent stem cells as a model of trophoblast differentiation in both normal development and disease. Proc. Natl. Acad. Sci. U. S. A. 113, E3882-91.
Hubrecht, A. A. W. (1908). Studies in mammalian embryology. I. The placentation of Erinaceus europaeus, with remarks on the phylogeny of the placenta. Q J Microsc Sci 30, 283–404.
Huch, M. and Koo, B.-K. (2015). Modeling mouse and human development using organoid cultures. Development 142, 3113–25.
Hustin, J. and Schaaps, J. P. (1987). Echographic [corrected] and anatomic studies of the maternotrophoblastic border during the first trimester of pregnancy. Am. J. Obstet. Gynecol. 157, 162–8.
Jain, A., Ezashi, T., Roberts, R. M. and Tuteja, G. (2017). Deciphering transcriptional regulation in human embryonic stem cells specified towards a trophoblast fate. Sci. Rep. 7, 17257.
James, J. L., Stone, P. R. and Chamley, L. W. (2005). The regulation of trophoblast differentiation by oxygen in the first trimester of pregnancy. Hum. Reprod. Update 12, 137–144.
James, J. L., Stone, P. R. and Chamley, L. W. (2007). The isolation and characterization of a population of extravillous trophoblast progenitors from first trimester human placenta. Hum. Reprod. 22, 2111–2119.
James, J. L., Hurley, D. G., Gamage, T. K. J. B., Zhang, T., Vather, R., Pantham, P., Murthi, P. and Chamley, L. W. (2015). Isolation and characterisation of a novel trophoblast side-population from first trimester placentae. REPRODUCTION 150, 449–462.
Jauniaux, E., Watson, A. L., Hempstock, J., Bao, Y.-P., Skepper, J. N. and Burton, G. J. (2000). Onset of Maternal Arterial Blood Flow and Placental Oxidative Stress. Am. J. Pathol. 157, 2111–2122.
Jauniaux, E., Collins, S. and Burton, G. J. (2018). Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging. Am. J. Obstet. Gynecol. 218, 75–87.
Jennewein, M. F., Goldfarb, I., Dolatshahi, S., Cosgrove, C., Noelette, F. J., Krykbaeva, M., Das, J., Sarkar, A., Gorman, M. J., Fischinger, S., et al. (2019). Fc Glycan-Mediated Regulation of Placental Antibody Transfer. Cell 178, 202-215.e14.
Jokhi, P. P., King, A. and Loke, Y. W. (1994). Reciprocal expression of epidermal growth factor receptor (EGF-R) and c-erbB2 by non-invasive and invasive human trophoblast populations. Cytokine 6, 433–442.
Kagami, M., Matsuoka, K., Nagai, T., Yamanaka, M., Kurosawa, K., Suzumori, N., Sekita, Y., Miyado, M., Matsubara, K., Fuke, T., et al. (2012). Paternal uniparental disomy 14 and related disorders. Epigenetics 7, 1142–1150.
Kam, E. P., Gardner, L., Loke, Y. W. and King, A. (1999). The role of trophoblast in the physiological change in decidual spiral arteries. Hum. Reprod. 14, 2131–8.
Kaufmann, P., Stark, J. and Stegner, H. E. (1977). The villous stroma of the human placenta. I. The ultrastructure of fixed connective tissue cells. Cell Tissue Res. 177, 105–21.
Kauma, S., Hayes, N. and Weatherford, S. (1997). The differential expression of hepatocyte growth factor and met in human placenta. J. Clin. Endocrinol. Metab. 82, 949–54.
Kauma, S. W., Bae-Jump, V. and Walsh, S. W. (1999). Hepatocyte growth factor stimulates trophoblast invasion: a potential mechanism for abnormal placentation in preeclampsia. J Clin Endocrinol Metab 84, 4092–4096.
King, A., Boocock, C., Sharkey, A. M., Gardner, L., Beretta, A., Siccardi, A. G. and Loke, Y. W. (1996). Evidence for the expression of HLAA-C class I mRNA and protein by human first trimester trophoblast. J. Immunol. 156, 2068–76.
King, A., Thomas, L. and Bischof, P. (2000a). Cell culture models of trophoblast II: trophoblast cell lines--a workshop report. Placenta 21 Suppl A, S113-9.
King, A., Burrows, T. D., Hiby, S. E., Bowen, J. M., Joseph, S., Verma, S., Lim, P. B., Gardner, L., Le Bouteiller, P., Ziegler, A., et al. (2000b). Surface Expression of HLA-C Antigen by Human Extravillous Trophoblast. Placenta 21, 376–387.
Knerr, I., Schubert, S. W., Wich, C., Amann, K., Aigner, T., Vogler, T., Jung, R., Dötsch, J., Rascher, W. and Hashemolhosseini, S. (2005). Stimulation of GCMa and syncytin via cAMP mediated PKA signaling in human trophoblastic cells under normoxic and hypoxic conditions. FEBS Lett. 579, 3991–8.
Kohler, P. O. and Bridson, W. E. (1971). Isolation of Hormone-Producing Clonal Lines of Human Choriocarcinoma 1. J. Clin. Endocrinol. Metab. 32, 683–687.
Koot, Y. E. M., van Hooff, S. R., Boomsma, C. M., van Leenen, D., Groot Koerkamp, M. J. A., Goddijn, M., Eijkemans, M. J. C., Fauser, B. C. J. M., Holstege, F. C. P. and Macklon, N. S. (2016). An endometrial gene expression signature accurately predicts recurrent implantation failure after IVF. Sci. Rep. 6, 19411.
Kovats, S., Main, E. K., Librach, C., Stubblebine, M., Fisher, S. J. and DeMars, R. (1990). A class I antigen, HLA-G, expressed in human trophoblasts. Science 248, 220–3.
Krendl, C., Shaposhnikov, D., Rishko, V., Ori, C., Ziegenhain, C., Sass, S., Simon, L., Müller, N. S., Straub, T., Brooks, K. E., et al. (2017). GATA2/3-TFAP2A/C transcription factor network couples human pluripotent stem cell differentiation to trophectoderm with repression of pluripotency. Proc. Natl. Acad. Sci. U. S. A. 114, E9579–E9588.
Kurman, R. J. (2002). Blaustein’s Pathology of the female genital tract. 5th ed. Springer.
Kurman, R. J., Main, C. S. and Chen, H. C. (1984). Intermediate trophoblast: a distinctive form of trophoblast with specific morphological, biochemical and functional features. Placenta 5, 349–69.
Ladines-Llave, C. A., Maruo, T., Manalo, A. S. and Mochizuki, M. (2013). Cytologic localization of epidermal growth factor and its receptor in developing human placenta varies over the course of pregnancy. Am. J. Obstet. Gynecol. 165, 1377–1382.
Lee, Y., Kim, K., Mckeon, F., Yang, A., Boyd, T. K., Crum, C. P. and Parast, M. M. (2007). A unifying concept of trophoblastic differentiation and malignancy defined by biomarker expression. 1003–1013.
Lee, C. Q., Gardner, L., Turco, M., Zhao, N., Murray, M. J., Coleman, N., Rossant, J., Hemberger, M. and Moffett, A. (2016a). What Is Trophoblast? A Combination of Criteria Define Human First-Trimester Trophoblast. Stem Cell Reports 6, 257–272.
Lee, C. Q. E., Gardner, L., Turco, M., Zhao, N., Murray, M. J., Coleman, N., Rossant, J., Hemberger, M. and Moffett, A. (2016b). What Is Trophoblast? A Combination of Criteria Define Human First-Trimester Trophoblast. Stem Cell Reports 6, 257–272.
Lee, C. Q. E., Gardner, L., Turco, M., Zhao, N., Murray, M. J., Coleman, N., Rossant, J., Hemberger, M. and Moffett, A. (2016c). What Is Trophoblast? A Combination of Criteria Define Human First-Trimester Trophoblast. Stem Cell Reports 6, 257–272.
Lee, J. S., Romero, R., Han, Y. M., Kim, H. C., Kim, C. J., Hong, J.-S. and Huh, D. (2016d). Placenta-on-a-chip: a novel platform to study the biology of the human placenta. J. Matern. Neonatal Med. 29, 1046–1054.
Lee, C. Q. E., Turco, M. Y., Gardner, L., Simons, B. D., Hemberger, M. and Moffett, A. (2018). Integrin α2 marks a niche of trophoblast progenitor cells in first trimester human placenta. Development 145, dev162305.
Li, Y., Moretto-Zita, M., Leon-Garcia, S. and Parast, M. M. (2014). p63 Inhibits Extravillous Trophoblast Migration and Maintains Cells in a Cytotrophoblast Stem Cell-Like State. Am. J. Pathol. 184, 3332–3343.
Liang, C.-Y., Wang, L.-J., Chen, C.-P., Chen, L.-F., Chen, Y.-H. and Chen, H. (2010). GCM1 regulation of the expression of syncytin 2 and its cognate receptor MFSD2A in human placenta. Biol. Reprod. 83, 387–95.
Liu, Y., Fan, X., Wang, R., Lu, X., Dang, Y.-L., Wang, H., Lin, H.-Y., Zhu, C., Ge, H., Cross, J. C., et al. (2018). Single-cell RNA-seq reveals the diversity of trophoblast subtypes and patterns of differentiation in the human placenta. Cell Res. 28, 819–832.
Macaulay, E. C., Chatterjee, A., Cheng, X., Baguley, B. C., Eccles, M. R. and Morison, I. M. (2017). The Genes of Life and Death: A Potential Role for Placental-Specific Genes in Cancer: Active retrotransposons in the placenta encode unique functional genes that may also be used by cancer cells to promote malignancy. Bioessays 39, 1700091.
Male, V., Gardner, L. and Moffett, A. (2012). Isolation of Cells from the Feto-Maternal Interface. Curr. Protoc. Immunol. 97, 7.40.1-7.40.11.
Malnou, E. C., Umlauf, D., Mouysset, M. and Cavaillé, J. (2019). Imprinted MicroRNA Gene Clusters in the Evolution, Development, and Functions of Mammalian Placenta. Front. Genet. 9, 706.
Marzioni, D., Banita, M., Felici, A., Paradinas, F. J., Newlands, E., De Nictolis, M., Mühlhauser, J. and Castellucci, M. (2001). Expression of ZO-1 and occludin in normal human placenta and in hydatidiform moles. Mol. Hum. Reprod. 7, 279–85.
Mayhew, T. M. (2014). Turnover of human villous trophoblast in normal pregnancy: what do we know and what do we need to know? Placenta 35, 229–40.
McPherson, J. D., Marra, M., Hillier, L., Waterston, R. H., Chinwalla, A., Wallis, J., Sekhon, M., Wylie, K., Mardis, E. R., Wilson, R. K., et al. (2001). A physical map of the human genome. Nature 409, 934–941.
Mi, S., Lee, X., Li, X., Veldman, G. M., Finnerty, H., Racie, L., LaVallie, E., Tang, X. Y., Edouard, P., Howes, S., et al. (2000). Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis. Nature 403, 785–789.
Mirkovic, J., Elias, K., Drapkin, R., Barletta, J. A., Quade, B. and Hirsch, M. S. (2015). GATA3 expression in gestational trophoblastic tissues and tumours. Histopathology 67, 636–644.
Moffett, A. and Colucci, F. (2015). Co-evolution of NK receptors and HLA ligands in humans is driven by reproduction. Immunol. Rev. 267, 283–297.
Moffett, A. and Loke, C. (2006). Immunology of placentation in eutherian mammals. Nat. Rev. Immunol. 6, 584–94.
Monier, I., Blondel, B., Ego, A., Kaminiski, M., Goffinet, F. and Zeitlin, J. (2015). Poor effectiveness of antenatal detection of fetal growth restriction and consequences for obstetric management and neonatal outcomes: a French national study. BJOG An Int. J. Obstet. Gynaecol. 122, 518–527.
Monk, D. (2015). Genomic imprinting in the human placenta. Am. J. Obstet. Gynecol. 213, S152-62.
Moreira de Mello, J. C., de Araújo, E. S. S., Stabellini, R., Fraga, A. M., de Souza, J. E. S., Sumita, D. R., Camargo, A. A. and Pereira, L. V (2010). Random X inactivation and extensive mosaicism in human placenta revealed by analysis of allele-specific gene expression along the X chromosome. PLoS One 5, e10947.
Morrish, D. W., Bhardwaj, D., Dabbagh, L. K., Marusyk, H. and Siy, O. (1987). Epidermal growth factor induces differentiation and secretion of human chorionic gonadotropin and placental lactogen in normal human placenta. J. Clin. Endocrinol. Metab. 65, 1282–90.
Morrish, D. W., Bhardwaj, D. and Paras, M. T. (1991). Transforming Growth Factor β1 Inhibits Placental Differentiation and Human Chorionic Gonadotropin and Human Placental Lactogen Secretion. Endocrinology 129, 22–26.
Natale, B. V., Schweitzer, C., Hughes, M., Globisch, M. A., Kotadia, R., Tremblay, E., Vu, P., Cross, J. C. and Natale, D. R. C. (2017). Sca-1 identifies a trophoblast population with multipotent potential in the mid-gestation mouse placenta. Sci. Rep. 7, 5575.
Nelson, A. C., Mould, A. W., Bikoff, E. K. and Robertson, E. J. (2016). Single-cell RNA-seq reveals cell type-specific transcriptional signatures at the maternal–foetal interface during pregnancy. Nat. Commun. 7, 11414.
Ng, R. K., Dean, W., Dawson, C., Lucifero, D., Madeja, Z., Reik, W. and Hemberger, M. (2008). Epigenetic restriction of embryonic cell lineage fate by methylation of Elf5. Nat. Cell Biol. 10, 1280–1290.
Niakan, K. K. and Eggan, K. (2013). Analysis of human embryos from zygote to blastocyst reveals distinct gene expression patterns relative to the mouse. Dev. Biol. 375, 54–64.
Nishioka, N., Inoue, K., Adachi, K., Kiyonari, H., Ota, M., Ralston, A., Yabuta, N., Hirahara, S., Stephenson, R. O., Ogonuki, N., et al. (2009). The Hippo signaling pathway components Lats and Yap pattern Tead4 activity to distinguish mouse trophectoderm from inner cell mass. Dev. Cell 16, 398–410.
Noguer-Dance, M., Abu-Amero, S., Al-Khtib, M., Lefevre, A., Coullin, P., Moore, G. E. and Cavaille, J. (2010). The primate-specific microRNA gene cluster (C19MC) is imprinted in the placenta. Hum. Mol. Genet. 19, 3566–3582.
Nordor, A. V., Nehar-Belaid, D., Richon, S., Klatzmann, D., Bellet, D., Dangles-Marie, V., Fournier, T. and Aryee, M. J. (2017). The early pregnancy placenta foreshadows DNA methylation alterations of solid tumors. Epigenetics 12, 793–803.
Novakovic, B., Gordon, L., Wong, N. C., Moffett, A., Manuelpillai, U., Craig, J. M., Sharkey, A. and Saffery, R. (2011). Wide-ranging DNA methylation differences of primary trophoblast cell populations and derived cell lines: implications and opportunities for understanding trophoblast function†. MHR Basic Sci. Reprod. Med. 17, 344–353.
O’Gorman, N., Wright, D., Poon, L. C., Rolnik, D. L., Syngelaki, A., de Alvarado, M., Carbone, I. F., Dutemeyer, V., Fiolna, M., Frick, A., et al. (2017). Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks’ gestation: comparison with NICE guidelines and ACOG recommendations. Ultrasound Obstet. Gynecol. 49, 756–760.
Okae, H., Toh, H., Sato, T., Hiura, H., Takahashi, S., Shirane, K., Kabayama, Y., Suyama, M., Sasaki, H. and Arima, T. (2018). Derivation of Human Trophoblast Stem Cells. Cell Stem Cell 22, 50-63.e6.
Parker, L. H., Schmidt, M., Jin, S.-W., Gray, A. M., Beis, D., Pham, T., Frantz, G., Palmieri, S., Hillan, K., Stainier, D. Y. R., et al. (2004). The endothelial-cell-derived secreted factor Egfl7 regulates vascular tube formation. Nature 428, 754–758.
Pattillo, R. A. and Gey, G. O. (1968). The Establishment Trophoblastic of a Cell Line of Human Cells in Vitro1. Cancer Res. 1231–1236.
Pattillo, R. A., Gey, G. O., Delfs, E. and Mattingly, R. F. (1968). In vitro identification of the trophoblastic stem cell of the human villous placenta. Am J Obs. Gynecol 100, 582–588.
Pavličev, M., Wagner, G. P., Chavan, A. R., Owens, K., Maziarz, J., Dunn-Fletcher, C., Kallapur, S. G., Muglia, L. and Jones, H. (2017). Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface. Genome Res. 27, 349–361.
Perez-Garcia, V., Fineberg, E., Wilson, R., Murray, A., Mazzeo, C. I., Tudor, C., Sienerth, A., White, J. K., Tuck, E., Ryder, E. J., et al. (2018a). Placentation defects are highly prevalent in embryonic lethal mouse mutants. Nature.
Perez-Garcia, V., Fineberg, E., Wilson, R., Murray, A., Mazzeo, C. I., Tudor, C., Sienerth, A., White, J. K., Tuck, E., Ryder, E. J., et al. (2018b). Placentation defects are highly prevalent in embryonic lethal mouse mutants. Nature 555, 463–468.
Petropoulos, S., Edsgärd, D., Reinius, B., Deng, Q., Panula, S. P., Codeluppi, S., Plaza Reyes, A., Linnarsson, S., Sandberg, R. and Lanner, F. (2016). Single-Cell RNA-Seq Reveals Lineage and X Chromosome Dynamics in Human Preimplantation Embryos. Cell 165, 1012–1026.
Pidoux, G., Gerbaud, P., Tsatsaris, V., Marpeau, O., Ferreira, F., Meduri, G., Guibourdenche, J., Badet, J., Evain-Brion, D. and Frendo, J.-L. (2007). Biochemical characterization and modulation of LH/CG-receptor during human trophoblast differentiation. J. Cell. Physiol. 212, 26–35.
Pidoux, G., Gerbaud, P., Dompierre, J., Lygren, B., Solstad, T., Evain-Brion, D. and Taskén, K. (2014). A PKA-ezrin-Cx43 signaling complex controls gap junction communication and thereby trophoblast cell fusion. J. Cell Sci. 127, 4172–85.
Pijnenborg, R. (1996). The Placental Bed. Hypertens. Pregnancy 15, 7–23.
Pijnenborg, R. and Vercruysse, L. (2013). A.A.W. Hubrecht and the naming of the trophoblast. Placenta 34, 314–319.
Pijnenborg, R., Dixon, G., Robertson, W. B. and Brosens, I. (1980). Trophoblastic invasion of human decidua from 8 to 18 weeks of pregnancy. Placenta 1, 3–19.
Pijnenborg, R., Vercruysse, L. and Hanssens, M. (2006). The Uterine Spiral Arteries In Human Pregnancy: Facts and Controversies. Placenta 27, 939–958.
Pijnenborg, R., Vercruysse, L. and Carter, A. M. (2011). Deep trophoblast invasion and spiral artery remodelling in the placental bed of the chimpanzee. Placenta 32, 400–408.
Poaty, H., Coullin, P., Peko, J. F., Dessen, P., Diatta, A. L., Valent, A., Leguern, E., Prévot, S., Gombé-Mbalawa, C., Candelier, J.-J., et al. (2012). Genome-Wide High-Resolution aCGH Analysis of Gestational Choriocarcinomas. PLoS One 7, e29426.
Ralston, A., Cox, B. J., Nishioka, N., Sasaki, H., Chea, E., Rugg-Gunn, P., Guo, G., Robson, P., Draper, J. S. and Rossant, J. (2010). Gata3 regulates trophoblast development downstream of Tead4 and in parallel to Cdx2. Development 137, 395–403.
Roberts, J. . and Redman, C. W. . (1993). Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 341, 1447–1451.
Roberts, R. M., Green, J. A. and Schulz, L. C. (2016). The evolution of the placenta. Reproduction 152, R179-89.
Roberts, R. M., Ezashi, T., Sheridan, M. A. and Yang, Y. (2018). Specification of trophoblast from embryonic stem cells exposed to BMP4†. Biol. Reprod. 99, 212–224.
Robin, C., Bollerot, K., Mendes, S., Haak, E., Crisan, M., Cerisoli, F., Lauw, I., Kaimakis, P., Jorna, R., Vermeulen, M., et al. (2009). Human placenta is a potent hematopoietic niche containing hematopoietic stem and progenitor cells throughout development. Cell Stem Cell 5, 385–95.
Robinson, J. M., Ackerman, W. E., Tewari, A. K., Kniss, D. A. and Vandre, D. D. (2009). Isolation of highly enriched apical plasma membranes of the placental syncytiotrophoblast. Anal. Biochem. 387, 87–94.
Rodesch, F., Simon, P., Donner, C. and Jauniaux, E. (1992). Oxygen measurements in endometrial and trophoblastic tissues during early pregnancy. Obstet. Gynecol. 80, 283—285.
Rolnik, D. L., da Silva Costa, F., Lee, T. J., Schmid, M. and McLennan, A. C. (2018). Association between fetal fraction on cell-free DNA testing and first-trimester markers for pre-eclampsia. Ultrasound Obstet. Gynecol. 52, 722–727.
Roopenian, D. C. and Akilesh, S. (2007). FcRn: the neonatal Fc receptor comes of age. Nat. Rev. Immunol. 7, 715–725.
Rossant, J. and Cross, J. C. (2001). Placental development: lessons from mouse mutants. Nat. Rev. Genet. 2, 538–48.
Sadovsky, Y., Mouillet, J.-F., Ouyang, Y., Bayer, A. and Coyne, C. B. (2015). The Function of TrophomiRs and Other MicroRNAs in the Human Placenta. Cold Spring Harb. Perspect. Med. 5, a023036.
Schlafke, S. and Enders, A. C. (1975). Cellular basis of interaction between trophoblast and uterus at implantation. Biol. Reprod. 12, 41–65.
Shahbazi, M. N., Jedrusik, A., Vuoristo, S., Recher, G., Hupalowska, A., Bolton, V., Fogarty, N. M. E., Campbell, A., Devito, L. G., Ilic, D., et al. (2016). Self-organization of the human embryo in the absence of maternal tissues. Nat. Cell Biol. 18, 700.
Shi, Q. J., Lei, Z. M., Rao, C. V and Lin, J. (1993). Novel role of human chorionic gonadotropin in differentiation of human cytotrophoblasts. Endocrinology 132, 1387–1395.
Shiroishi, M., Kuroki, K., Rasubala, L., Tsumoto, K., Kumagai, I., Kurimoto, E., Kato, K., Kohda, D. and Maenaka, K. (2006). Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d). Proc. Natl. Acad. Sci. 103, 16412–16417.
Simpson, R. A., Mayhew, T. M. and Barnes, P. R. (1992). From 13 weeks to term, the trophoblast of human placenta grows by the continuous recruitment of new proliferative units: A study of nuclear number using the disector. Placenta 13, 501–512.
Smith, G. C. (2010). First-trimester determination of complications of late pregnancy. JAMA 303, 561–562.
Soares, M. J., Chakraborty, D., Karim Rumi, M. A., Konno, T. and Renaud, S. J. (2012). Rat placentation: An experimental model for investigating the hemochorial maternal-fetal interface. Placenta 33, 233–243.
Soncin, F., Khater, M., To, C., Pizzo, D., Farah, O., Wakeland, A., Arul Nambi Rajan, K., Nelson, K. K., Chang, C.-W., Moretto-Zita, M., et al. (2018). Comparative analysis of mouse and human placentae across gestation reveals species-specific regulators of placental development. Development 145, dev156273.
Sonderegger, S., Husslein, H., Leisser, C. and Knofler, M. (2007). Complex expression pattern of Wnt ligands and frizzled receptors in human placenta and its trophoblast subtypes. Placenta 28 Suppl A, S97-102.
Spencer, T. E., Kelleher, A. M. and Bartol, F. F. (2019). Development and Function of Uterine Glands in Domestic Animals. Annu. Rev. Anim. Biosci. 7, 125–147.
Stefanoska, I., Jovanović Krivokuća, M., Vasilijić, S., Ćujić, D. and Vićovac, L. (2013). Prolactin stimulates cell migration and invasion by human trophoblast in vitro. Placenta 34, 775–83.
Stirparo, G. G., Boroviak, T., Guo, G., Nichols, J., Smith, A. and Bertone, P. (2018). Integrated analysis of single-cell embryo data yields a unified transcriptome signature for the human pre-implantation epiblast. Development 145, dev158501.
Straszewski-Chavez, S. L., Abrahams, V. M., Alvero, A. B., Aldo, P. B., Ma, Y., Guller, S., Romero, R. and Mor, G. (2009). The Isolation and Characterization of a Novel Telomerase Immortalized First Trimester Trophoblast Cell Line, Swan 71. Placenta 30, 939–948.
Strumpf, D., Mao, C.-A., Yamanaka, Y., Ralston, A., Chawengsaksophak, K., Beck, F. and Rossant, J. (2005). Cdx2 is required for correct cell fate specification and differentiation of trophectoderm in the mouse blastocyst. Development 132, 2093–2102.
Sun, J. C., Ugolini, S. and Vivier, E. (2014). Immunological memory within the innate immune system. EMBO J. 33, 1295–303.
Suryawanshi, H., Morozov, P., Straus, A., Sahasrabudhe, N., Max, K. E. A., Garzia, A., Kustagi, M., Tuschl, T. and Williams, Z. (2018). A single-cell survey of the human first-trimester placenta and decidua. Sci. Adv. 4, eaau4788.
Takao, T., Asanoma, K., Kato, K., Fukushima, K., Tsunematsu, R., Hirakawa, T., Matsumura, S., Seki, H., Takeda, S. and Wake, N. (2011). Isolation and Characterization of Human Trophoblast Side-Population (SP) Cells in Primary Villous Cytotrophoblasts and HTR-8/SVneo Cell Line. PLoS One 6, e21990.
Takebe, T. and Wells, J. M. (2019). Organoids by design. Science (80-. ). 364, 956–959.
Tanaka, S., Kunath, T., Hadjantonakis, A. K., Nagy, A. and Rossant, J. (1998). Promotion of trophoblast stem cell proliferation by FGF4. Science 282, 2072–5.
Teasdale, F. and Jean-Jacques, G. (1985). Morphometric evaluation of the microvillous surface enlargement factor in the human placenta from mid-gestation to term. Placenta 6, 375–81.
Tilburgs, T., Crespo, A. C., van der Zwan, A., Rybalov, B., Raj, T., Stranger, B., Gardner, L., Moffett, A. and Strominger, J. L. (2015). Human HLA-G+ extravillous trophoblasts: Immune-activating cells that interact with decidual leukocytes. Proc Natl Acad Sci U S A 112, 7219–7224.
Tsang, J. C. H., Vong, J. S. L., Ji, L., Poon, L. C. Y., Jiang, P., Lui, K. O., Ni, Y.-B., To, K. F., Cheng, Y. K. Y., Chiu, R. W. K., et al. (2017). Integrative single-cell and cell-free plasma RNA transcriptomics elucidates placental cellular dynamics. Proc. Natl. Acad. Sci. 114, E7786 LP-E7795.
Turco, M. Y., Gardner, L., Hughes, J., Cindrova-Davies, T., Gomez, M. J., Farrell, L., Hollinshead, M., Marsh, S. G. E., Brosens, J. J., Critchley, H. O., et al. (2017). Long-term, hormone-responsive organoid cultures of human endometrium in a chemically defined medium. Nat Cell Biol 19, 568–577.
Turco, M. Y., Gardner, L., Kay, R. G., Hamilton, R. S., Prater, M., Hollinshead, M. S., McWhinnie, A., Esposito, L., Fernando, R., Skelton, H., et al. (2018). Trophoblast organoids as a model for maternal–fetal interactions during human placentation. Nature 564, 263–267.
Vacca, P., Chiossone, L., Mingari, M. C. and Moretta, L. (2019). Heterogeneity of NK Cells and Other Innate Lymphoid Cells in Human and Murine Decidua   . Front. Immunol.   10, 170.
Vatten, L. J. and Skjaerven, R. (2004). Offspring sex and pregnancy outcome by length of gestation. Early Hum. Dev. 76, 47–54.
Velicky, P., Meinhardt, G., Plessl, K., Vondra, S., Weiss, T., Haslinger, P., Lendl, T., Aumayr, K., Mairhofer, M., Zhu, X., et al. (2018). Genome amplification and cellular senescence are hallmarks of human placenta development. PLOS Genet. 14, e1007698.
Vento-Tormo, R., Efremova, M., Botting, R. A., Turco, M. Y., Vento-Tormo, M., Meyer, K. B., Park, J.-E., Stephenson, E., Polański, K., Goncalves, A., et al. (2018). Single-cell reconstruction of the early maternal–fetal interface in humans. Nature 563, 347–353.
Wakeland, A. K., Soncin, F., Moretto-Zita, M., Chang, C.-W., Horii, M., Pizzo, D., Nelson, K. K., Laurent, L. C. and Parast, M. M. (2017). Hypoxia Directs Human Extravillous Trophoblast Differentiation in a Hypoxia-Inducible Factor–Dependent Manner. Am. J. Pathol. 187, 767–780.
Wikström, A.-K., Gunnarsdóttir, J. and Cnattingius, S. (2012). The paternal role in pre-eclampsia and giving birth to a small for gestational age infant; a population-based cohort study. BMJ Open 2, e001178.
Xu, P., Wang, Y. L., Zhu, S. J., Luo, S. Y., Piao, Y. S. and Zhuang, L. Z. (2000). Expression of matrix metalloproteinase-2, -9, and -14, tissue inhibitors of metalloproteinase-1, and matrix proteins in human placenta during the first trimester. Biol. Reprod. 62, 988–94.
Xu, R.-H., Chen, X., Li, D. S., Li, R., Addicks, G. C., Glennon, C., Zwaka, T. P. and Thomson, J. a (2002). BMP4 initiates human embryonic stem cell differentiation to trophoblast. Nat. Biotechnol. 20, 1261–4.
Yagi, R., Kohn, M. J., Karavanova, I., Kaneko, K. J., Vullhorst, D., DePamphilis, M. L. and Buonanno, A. (2007). Transcription factor TEAD4 specifies the trophectoderm lineage at the beginning of mammalian development. Development 134, 3827–36.
Yin, X., Mead, B. E., Safaee, H., Langer, R., Karp, J. M. and Levy, O. (2016). Engineering Stem Cell Organoids. Cell Stem Cell 18, 25–38.
Yoffe, L., Gilam, A., Yaron, O., Polsky, A., Farberov, L., Syngelaki, A., Nicolaides, K., Hod, M. and Shomron, N. (2018). Early Detection of Preeclampsia Using Circulating Small non-coding RNA. Sci. Rep. 8, 3401.
Young, S. L. (2017). Evaluation of endometrial function: a Heraclean or Sisyphean task? Fertil. Steril. 108, 604–605.
Zdravkovic, T., Nazor, K. L., Larocque, N., Gormley, M., Donne, M., Hunkapillar, N., Giritharan, G., Bernstein, H. S., Wei, G., Hebrok, M., et al. (2015). Human stem cells from single blastomeres reveal pathways of embryonic or trophoblast fate specification. Development 142, 4010–25.
Zeisler, H., Llurba, E., Chantraine, F., Vatish, M., Staff, A. C., Sennström, M., Olovsson, M., Brennecke, S. P., Stepan, H., Allegranza, D., et al. (2016). Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia. N. Engl. J. Med. 374, 13–22.
Zhou, Y., Fisher, S. J., Janatpour, M., Genbacev, O., Dejana, E., Wheelock, M. and Damsky, C. H. (1997). Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? J. Clin. Invest. 99, 2139–51.



Figure legends

Figure 1. The early stages of human placental development.
Diagram depicting the early steps in placenta formation following blastocyst implantation. a. and b. are pre-lacunar stages, c. lacunar stage and d. primary villous stage. Refer to text for explanation. Abbreviations: LE, luminal epithelium; GE, glandular epithelium; vs, blood vessels; ICM, inner cell mass; TE, trophectoderm; pr. syn, primary syncytium; mn. tr, mononuclear trophoblast; ac, amniotic cavity; exm, extraembryonic mesoderm; 1°ys, primary yolk sac; lac, lacunae; eec, extraembryonic coelom; cs, cytotrophoblastic shell;

Figure 2. The maternal-fetal interface and the trophoblast subtypes.
Cells contained within the villi of the early first trimester placenta and the major trophoblast subtypes in relation to the decidua are represented. The decidual portion has been illustrated contracted to include the myometrium. Synctiotrophoblast is shown in grey, villous cytotrophoblast in violet, and cytotrophoblast cell column (CCC) and extravillous trophoblast (EVT) populations (endovascular and interstitial) are shown in orange. The endpoint of EVT differentiation, placental bed giant cells, are shown in purple. 

Figure 3. Emerging technologies for the study of human trophoblast biology and placental development.
New techniques that can be applied to investigate the fundamental biology of human placentation are shown. 

23